Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

2.9K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.9K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

602
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
602
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of Preoperative Echocardiography in Resource-Limited Settings and Delayed Patient Care.

Cureus·2026
Same author

Trends and projections for Alzheimer's disease and other dementias in Kenya: Analysis of the global burden of disease data 1990-2021 in relation to Africa and the world.

Journal of Alzheimer's disease : JAD·2026
Same author

Not All That Hurts Is Malignant: A Painful Case of Focal Nodular Hyperplasia.

Cureus·2025
Same author

When It's Not Cancer: An Uncommon Case of Tubular Ectasia of the Epididymis as a Post-vasectomy Sequela.

Cureus·2025
Same author

Prevalence and risk factors of hypertension among clients seeking care at Selected Healthcare Facilities in Kenya.

PloS one·2025
Same author

End user experiences of an electronic health records platform in a tertiary hospital system in Kenya.

PloS one·2025
Same journal

Indian Council of Medical Research's network of pulmonary fibrosis (INPF): A big step forward towards understanding interstitial lung diseases in India.

Lung India : official organ of Indian Chest Society·2026
Same journal

Perfect diagnostic accuracy in a small derivation cohort and outdated classification criteria: Methodological concerns regarding miR-21 as a biomarker for chronic obstructive pulmonary disease-associated pulmonary hypertension.

Lung India : official organ of Indian Chest Society·2026
Same journal

Serogroup characterisation, co-pathogen causality, and environmental surveillance gaps in a cross-sectional study of Legionella pneumophila in hospital-acquired pneumonia.

Lung India : official organ of Indian Chest Society·2026
Same journal

Efficacy of nebulised vs intravenous tranexamic acid in management of non-massive haemoptysis: A randomised controlled trial.

Lung India : official organ of Indian Chest Society·2026
Same journal

Methodological considerations on 'an international collaborative initiative to screen primary ciliary dyskinesia with high-speed video microscopy and nasal nitric oxide at a tertiary referral centre in South India'.

Lung India : official organ of Indian Chest Society·2026
Same journal

When the lung reaches the eye: Ocular metastasis from large-cell neuroendocrine carcinoma.

Lung India : official organ of Indian Chest Society·2026
See all related articles

Related Experiment Video

Updated: Mar 15, 2026

Methods for Detecting Cough and Airway Inflammation in Mice
04:33

Methods for Detecting Cough and Airway Inflammation in Mice

Published on: August 2, 2024

1.4K

A fatty cough.

Sayed K Ali1, Hammad Bhatti1

  • 1Orlando Veteran Affairs Medical Center, FL, USA.

Lung India : Official Organ of Indian Chest Society
|September 15, 2016
PubMed
Summary
This summary is machine-generated.

Lipoid pneumonia, a rare lung condition, results from lipid buildup. Diagnosis involves imaging and bronchoalveolar lavage, with treatment focused on removing causative agents and supportive care.

Keywords:
Diagnosisfatty pneumoniatreatment

More Related Videos

Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid
05:43

Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid

Published on: January 10, 2025

1.3K
Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.8K

Related Experiment Videos

Last Updated: Mar 15, 2026

Methods for Detecting Cough and Airway Inflammation in Mice
04:33

Methods for Detecting Cough and Airway Inflammation in Mice

Published on: August 2, 2024

1.4K
Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid
05:43

Establishment of a Mouse Model with Cough Hypersensitivity via Inhalation of Citric Acid

Published on: January 10, 2025

1.3K
Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
03:25

Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment

Published on: December 27, 2024

1.8K

Area of Science:

  • Pulmonology
  • Pathology

Background:

  • Lipoid pneumonia is a rare lung disease characterized by lipid accumulation in alveoli.
  • It can stem from exogenous sources (e.g., aspiration of oily substances) or endogenous lipid metabolism disorders.

Purpose of the Study:

  • To summarize the key aspects of lipoid pneumonia, including its causes, clinical presentation, diagnostic methods, and treatment strategies.

Main Methods:

  • Review of existing literature on lipoid pneumonia.
  • Analysis of diagnostic tools such as high-resolution computed tomography (HRCT) and bronchoalveolar lavage (BAL).

Main Results:

  • Symptoms vary from asymptomatic to severe respiratory distress, including chest pain, fever, and shortness of breath.
  • HRCT is crucial for identifying lipid deposits, while BAL can confirm the presence of lipids.

Conclusions:

  • Diagnosis relies on clinical suspicion, imaging, and BAL findings.
  • Management involves eliminating the offending agent and supportive care; anti-inflammatory agents may benefit severe cases.